Chan A, Moy B, Mansi J, Ejlertsen B, et al. Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive
Early-stage Breast Cancer From the Phase III ExteNET Trial. Clin Breast Cancer 2020 Oct 6. pii: S1526-8209(20)30258.
PMID: 33183970